Check out our most popular compounded medications! Get Started
The Tolterodine Tartrate 2 mg/5 mL Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method for administering the active ingredient, tolterodine tartrate. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills, such as children and the elderly. Tolterodine tartrate is commonly used in the treatment of overactive bladder, which includes symptoms of urinary frequency, urgency, and incontinence. By providing this medication in a liquid form, Bayview Pharmacy ensures that patients who are unable to take solid dosage forms can still receive their necessary treatment for these disease states effectively and safely.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Tolterodine Tartrate 2 mg/5 mL Oral Liquid is a specially compounded medication designed for ease of administration and precise dosing. This formulation is particularly beneficial for patients who have difficulty swallowing pills, such as children and the elderly, or those with dysphagia. Tolterodine Tartrate is an antimuscarinic agent that works by selectively blocking the muscarinic receptors in the bladder. This action helps to reduce the frequency of bladder contractions, decrease urinary urgency, and increase the capacity of the bladder, thereby managing symptoms of overactive bladder (OAB), including frequent urination, urgency, and incontinence.
The liquid form ensures that patients who are unable to take solid dosage forms can still receive their medication in a reliable and controlled manner. The 2 mg/5 mL concentration allows for flexible dosing, which can be adjusted according to the specific needs of the patient. This is particularly important in the pediatric population, where dosing often needs to be calculated based on body weight. The oral liquid formulation also offers a faster onset of action compared to solid dosage forms, as it does not require disintegration and dissolution in the stomach, which can be advantageous for rapid symptom relief.
For prescribers, it is important to note that the pharmacokinetics of the liquid formulation may differ from those of the tablet form, and this should be taken into account when determining the dosing regimen. Additionally, patients should be monitored for potential anticholinergic side effects, such as dry mouth, constipation, and blurred vision, which are common to medications in this class. As with any medication, adherence to prescribed dosing schedules is crucial for optimal therapeutic outcomes.
Bayview Pharmacy is committed to providing high-quality, customized medications to meet the unique needs of each patient. Our team of expert compounding pharmacists ensures that each formulation is prepared with precision and care. If you have any questions about Tolterodine Tartrate 2 mg/5 mL Oral Liquid or its use in treating overactive bladder symptoms, please do not hesitate to reach out to us.
Tolterodine tartrate is a medication that is primarily used to treat symptoms of an overactive bladder, such as frequent or urgent urination and urinary incontinence. As a muscarinic receptor antagonist, tolterodine works by relaxing the muscles in the bladder, thus reducing urinary urgency and frequency. When considering the use of tolterodine tartrate 2 mg/5 mL oral liquid, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects.
One significant interaction is with drugs that are strong inhibitors of the liver enzyme CYP3A4, such as clarithromycin, ketoconazole, and ritonavir. These medications can increase the concentration of tolterodine in the blood, potentially leading to an increased risk of side effects, including dry mouth, constipation, headache, and dizziness. If a patient is taking a CYP3A4 inhibitor, they may require a lower dose of tolterodine.
Conversely, drugs that induce CYP3A4, such as rifampin, carbamazepine, and phenytoin, may decrease the plasma concentration of tolterodine, potentially reducing its therapeutic effect.
Additionally, tolterodine should be used with caution in combination with other anticholinergic drugs, as the additive effects may increase the risk of anticholinergic side effects, such as blurred vision, dry mouth, urinary retention, and constipation. Examples of anticholinergic drugs include atropine, benztropine, and some antihistamines like diphenhydramine.
Patients taking class IA (e.g., quinidine, procainamide) or class III (e.g., amiodarone, sotalol) antiarrhythmic medications should also be cautious, as the combination with tolterodine may increase the risk of QT prolongation, a serious heart rhythm condition. Electrocardiogram (ECG) monitoring may be recommended when these drugs are co-administered.
It is also important to consider the potential for interaction with other medications that are metabolized by the liver, as tolterodine may compete for the same metabolic pathways, potentially altering the levels of either drug. This includes a wide range of medications, such as certain statins, antidepressants, and antifungal agents.
Patients should be advised to inform their healthcare provider of all medications they are taking, including over-the-counter drugs, herbal supplements, and vitamins, to ensure that any potential interactions can be assessed and managed appropriately. Prescribers should review the patient's medication profile for potential interactions before initiating tolterodine tartrate therapy and monitor for any adverse effects or changes in therapeutic efficacy during treatment.
If you have any questions or require further information regarding the drug interactions associated with tolterodine tartrate 2 mg/5 mL oral liquid, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the necessary support and guidance to support the safe and appropriate medication use.
The Tolterodine Tartrate 2 mg/5 mL Oral Liquid is a specially compounded medication designed for ease of administration and precise dosing. Tolterodine tartrate, the active ingredient, is a muscarinic receptor antagonist that works by targeting the bladder's smooth muscle. When ingested, tolterodine selectively blocks the action of acetylcholine on muscarinic receptors, which are found in high concentration in the bladder. This action reduces the spasm of the bladder muscle, which in turn decreases urinary urgency, frequency, and incontinence episodes associated with overactive bladder syndrome.
Upon oral administration, the liquid formulation of tolterodine tartrate is absorbed into the bloodstream through the gastrointestinal tract. The liquid dosage form is particularly beneficial for patients who have difficulty swallowing pills, such as children, the elderly, or those with dysphagia. It also allows for flexible dosing, which can be adjusted according to the specific needs of the patient. The medication is then metabolized in the liver and its metabolites are primarily excreted through the kidneys.
The efficacy of tolterodine tartrate in treating symptoms of overactive bladder has been well documented in clinical trials. By reducing the frequency of muscle contractions in the bladder, tolterodine tartrate helps to control the release of urine and manage the symptoms of bladder instability. This can significantly improve the quality of life for patients suffering from this condition, allowing them to engage in daily activities with greater confidence and fewer interruptions.
Additionally, potential interactions with other medications should be reviewed by a healthcare provider. As with any medication, adherence to prescribed dosing and monitoring for side effects is crucial for optimal outcomes.
At Bayview Pharmacy, we are committed to providing high-quality, customized medications to meet the unique needs of our patients. If you have any questions about the Tolterodine Tartrate 2 mg/5 mL Oral Liquid or its suitability for your condition, please do not hesitate to reach out to us. Our team of compounding pharmacists is here to support you with the information and guidance you need to make informed decisions about your healthcare.
Tolterodine Tartrate Oral Liquid is used to treat symptoms of an overactive bladder, such as frequent or urgent urination and incontinence (urine leakage).
This medication should be taken exactly as prescribed by your healthcare provider. The liquid should be measured with a proper dosing spoon or syringe to ensure the correct amount is taken.
While this liquid formulation is convenient for pediatric patients who have trouble swallowing pills, the suitability for children should be determined by a pediatrician based on the child's age, weight, and medical condition.
Yes, this liquid formulation is often easier for elderly patients to swallow compared to solid dosage forms. However, dosing may need to be adjusted for this population.
Possible side effects can include dry mouth, constipation, headache, and dizziness. If you experience any severe side effects or symptoms that do not go away, consult your healthcare provider immediately.
If you miss a dose of Tolterodine Tartrate Oral Liquid, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take double doses to make up for the missed one.
Some medications may interact with Tolterodine Tartrate, so it's important to inform your healthcare provider about all the medications you are taking. They will advise whether any medication adjustments are necessary.
Store this medication at room temperature away from light and moisture, and keep it out of reach of children. Do not store in the bathroom or freeze the liquid.
If an overdose is suspected, seek immediate medical attention or contact Poison Control. Symptoms of overdose may include severe dizziness, difficulty breathing, or an abnormally fast or irregular heartbeat.
Some patients may notice an improvement in symptoms within a few days, but it can take up to several weeks to experience the full benefits of this medication. Maintain regular communication with your healthcare provider to determine the effectiveness of the treatment.
Since Tolterodine Tartrate can cause dizziness and blurred vision, it may impair your ability to drive or operate machinery. Avoid these activities until you know how the medication affects you.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
